Patents Assigned to UNIVERSITY OF ALBANY
  • INDOLE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF
    Publication number: 20220296604
    Abstract: Indole compounds are disclosed. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, diabetes complications, inflammation, and neurodegeneration, obesity, cancer, schemia/reperfusion injury, cardiovascular disease and other diseases related to RAGE activity.
    Type: Application
    Filed: August 5, 2020
    Publication date: September 22, 2022
    Applicants: NEW YORK UNIVERSITY, UNIVERSITY OF ALBANY
    Inventors: Ann Marie SCHMIDT, Ravichandran RAMASAMY, Alexander SHEKHTMAN, Vivek RAI, Michaele B. MANIGRASSO
  • T-box riboswitch-binding anti-bacterial compounds
    Patent number: 10266527
    Abstract: The present disclosure identifies compounds that bind to a t-RNA-dependent riboswitch of aaRS gene expression unique to Gram-positive bacteria. The compounds have anti-bacterial activity.
    Type: Grant
    Filed: July 23, 2014
    Date of Patent: April 23, 2019
    Assignee: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF ALBANY
    Inventor: Paul F. Agris
  • Nucleic acids that encode sodium channel
    Patent number: 8198425
    Abstract: Isolated nucleic acid comprising a nucleotide sequence that codes for a mutant mammalian Nav1 protein are disclosed.
    Type: Grant
    Filed: April 6, 2010
    Date of Patent: June 12, 2012
    Assignee: The Research Foundation of State University of New York, University at Albany
    Inventor: Sho-Ya Wang